| mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
lapatinib |
FIMM |
pan-cancer |
AAC |
-0.028 |
0.9 |
| mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
-0.028 |
0.9 |
| mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |